Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Seaman, D (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S156000
Reexamination Certificate
active
08003666
ABSTRACT:
The present invention relates to [7-[(7S)-7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hemihydrate. This hemihydrate is stable and easy to prepare, and has excellent properties for a pharmaceutical bulk powder.
REFERENCES:
patent: 5587386 (1996-12-01), Hayakawa et al.
patent: 6900225 (2005-05-01), Takemura et al.
patent: 7563805 (2009-07-01), Takahashi et al.
patent: 2 231475 (1990-09-01), None
patent: 2002 255962 (2002-09-01), None
patent: 2005-146386 (2005-05-01), None
patent: 2003/076428 (2003-09-01), None
patent: 2006 123767 (2006-11-01), None
patent: 2006 123792 (2006-11-01), None
patent: WO 2006/123792 (2006-11-01), None
Bozdogan, J Antimicrobial Chemotherapy, vol. 52, pp. 864-868, 2003.
Ono Makoto
Yoshida Shoko
Daiichi Sankyo Company, Limited
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Seaman D
LandOfFree
Hydrate for medical purposes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrate for medical purposes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrate for medical purposes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2751965